（英文原文）TrialSummaryAleCardioDescription:Thegoalofthetrialwastoevaluatetreatmentwiththeperoxisomeproliferator-activatedreceptor(PPAR)dual-agonistaleglitazarcomparedwithplaceboamongtype2diabeticpatientshospitalizedforanacutecoronarysyndrome.AleglitazarisadualagonistofPPAR-αand-γreceptors.TheprimaryeffectofPPAR-αactivationistoimproveplasmalipidprofile,whiletheprimaryeffectofPPAR-γactivati...
